Texas Biotech (TXB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Texas Biotech (TXB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: timmask who wrote (201)	6/10/1997 3:03:00 PM
From: (no name provided)	of 834

Tim, I would suspect no impact whatsoever. The data is out. The data is excellent. The valuation of this stock still continues to defy rational valuation. The market cap as I write this is $135 million. It is very likely to have an approved drug this year. Compare this to: VIRS (Triangle Pharm) Market cap $500 million. Drugs in phase II. Legal questions regarding the drugs. Will be entering a very mature market in 2000. NXCO (Neurex) Market cap $350 million. Probably a reasonable comparable. NDA pending. I'm not sure you can find a company that has an NDA or one soon to be filed with a market cap below $200 million. If anyone knows of one, please let me know. Kafka666

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next